3
↑3
↓0
—0
Evidence suggests Magnesium mayincreaseNeuroprotection.
4 studies (3 claims)
Emerging evidence
Study Claims
| Intervention | Direction | Endpoint | Type | Population | Dosage | Title |
|---|---|---|---|---|---|---|
| magnesium sulfate for fetal neuroprotection | Increases - has an overall beneficial effect on the infant | fetal neuroprotection | Human | patients with clinical chorioamnionitis between 24 0/7 and 33 6/7 weeks of gestation, and possibly between 23 0/7 and 23 6/7 weeks of gestation | Not specified | Management of clinical chorioamnionitis: an evidence-based approach.cited 61× |
| magnesium | No effect - exciting translational therapies on the horizon | neuroprotection | Human | patients with spinal cord injuries | Not specified | Concise Review: Bridging the Gap: Novel Neuroregenerative and Neuroprotective Strategies in Spinal Cord Injury.cited 151× |
| Magnesium | Increases - promising | neuroprotection | Human | neonates with neonatal encephalopathy | Not specified | Therapies for neonatal encephalopathy: Targeting the latent, secondary and tertiary phases of evolving brain injury.cited 34× |
| magnesium sulfate | Increases - exhibited neuroprotective effects | neuroprotection | Human | pregnant women with imminent preterm birth before 30 to 34 weeks of gestation | Not specified | Pharmacological Neuroprotection of the Preterm Brain: Current Evidence and Perspectives.cited 5× |